- Home
- BCBP vs ALEC Comparison
BCBP vs ALEC Comparison
Compare BCBP & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCBP | ALEC |
|---|---|---|
| Founded | 2000 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.1M | 158.8M |
| IPO Year | 2005 | 2019 |
Fundamental Metrics
Financial Performance| Metric | BCBP | ALEC |
|---|---|---|
| Price | $10.25 | $1.50 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $10.00 | $4.83 |
| AVG Volume (30 Days) | 164.8K | ★ 772.7K |
| Earning Date | 04-21-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.10% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | N/A | ★ $21,045,000.00 |
| Revenue This Year | $85.26 | $2.03 |
| Revenue Next Year | $6.14 | $29.87 |
| P/E Ratio | $38.58 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.31 | $1.09 |
| 52 Week High | $11.71 | $3.40 |
Technical Indicators
Market Signals| Indicator | BCBP | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 46.51 | 39.93 |
| Support Level | $9.67 | $1.37 |
| Resistance Level | $10.60 | $1.60 |
| Average True Range (ATR) | 0.28 | 0.12 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 51.55 | 20.83 |
Price Performance
Historical ComparisonAbout BCBP BCB Bancorp Inc. (NJ)
BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.